Identifying low value pathology test ordering in hospitalised patients: a retrospective cohort study across two hospitals.


Journal

Pathology
ISSN: 1465-3931
Titre abrégé: Pathology
Pays: England
ID NLM: 0175411

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 06 01 2019
revised: 27 05 2019
accepted: 26 06 2019
pubmed: 2 9 2019
medline: 29 2 2020
entrez: 2 9 2019
Statut: ppublish

Résumé

The push to identify low value care has led to scrutiny of pathology test re-ordering. The objective of this study was to identify the patterns of ordering pathology tests among inpatients in teaching hospitals and model strategies to reduce unnecessary testing. This was a retrospective cohort study of all adult medical and surgical inpatients admitted to one major teaching hospital and one rural hospital in the same health district over 2 years. Obstetric, gynaecological, intensive care, elective/day procedures and dialysis admissions were excluded. Orders for electrolytes, urea and creatinine (EUC), full blood count (FBC), thyroid stimulating hormone (TSH), glycated haemoglobin (HbA1c), vitamin D, and troponin, date of order, and value of the resulting test, were obtained from a health district data warehouse. Pathology results were mapped to each inpatient day. EUC and FBC constituted over 90% of all inpatient pathology requests for these six tests. Between 40-45% of inpatients had EUC and/or FBC performed daily. After the first couple of tests, the retest interval was consistently around 24 hours, regardless of the previous value of the test, consistent with a culture of routine ordering. This was less pronounced in the rural hospital compared to the urban teaching hospital. Lockouts (applied when previous tests normal) or minimum retest intervals (applied to previously normal and abnormal tests) of various lengths were tested on the data to find optimal combinations that reduced unnecessary tests without missing too many very abnormal tests. A lockout of 48 hours for EUC and 48 hour lockout combined with a 12 hour minimum retest interval for FBC appear optimal to reduce over ordering and could save approximately AU$400/inpatient bed per year at a single teaching hospital. There is evidence of low value re-ordering of EUC and FBC pathology tests. Implementation of a computerised physician order entry system with inbuilt prompts to restrict unnecessary re-ordering of pathology tests may be a practical solution.

Identifiants

pubmed: 31472983
pii: S0031-3025(19)30335-6
doi: 10.1016/j.pathol.2019.06.003
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

621-627

Informations de copyright

Copyright © 2019 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.

Auteurs

Alexis Hure (A)

School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia.

Kerrin Palazzi (K)

Hunter Medical Research Institute, Newcastle, NSW, Australia.

Roseanne Peel (R)

School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia.

David Geraghty (D)

Applications Development ICT Services Hunter New England Local Health District, Newcastle, NSW, Australia.

Phillip Collard (P)

Applications Development ICT Services Hunter New England Local Health District, Newcastle, NSW, Australia.

Theo De Malmanche (T)

New South Wales Health Pathology, Immunology, Hunter New England Local Health District, Newcastle, NSW, Australia.

Huy Tran (H)

New South Wales Health Pathology, Immunology, Hunter New England Local Health District, Newcastle, NSW, Australia.

Penny Reeves (P)

Hunter Medical Research Institute, Newcastle, NSW, Australia.

Andrew Searles (A)

School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia; Hunter Medical Research Institute, Newcastle, NSW, Australia.

Louisa Jorm (L)

Centre for Big Data Research in Health, University of New South Wales, Sydney, NSW, Australia.

John Attia (J)

School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia; Hunter Medical Research Institute, Newcastle, NSW, Australia. Electronic address: john.attia@newcastle.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH